Name | {4-[Bis(4-chlorophenyl)methyl]-1-piperazinyl}(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone |
---|---|
Synonyms |
T6N DNTJ AYR DG&R DG& DV- ET5NOJ C1 DNW
MFCD22666407 Methanone, [4-[bis(4-chlorophenyl)methyl]-1-piperazinyl](5-methyl-4-nitro-3-isoxazolyl)- [4-[Bis(4-chlorophenyl)methyl]-1-piperazinyl]-(5-methyl-4-nitro-3-isoxazolyl)methanone {4-[Bis(4-chlorophenyl)methyl]-1-piperazinyl}(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone |
Description | ML-210,the most potent compound in the nitroisoxazole series, is a selective covalent inhibitor of glutathione peroxidase 4 (GPX4) by binding the selenocysteine residue[1]. ML-210 has IC50s of 71 nM, 272 nM and 107nM for BJeLR (HRASV12), BJeH-LT (without HRASV12) and DRD cell lines, respectively[2]. |
---|---|
Related Catalog | |
Target |
Glutathione Peroxidase 4 (GPX4)[1] |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 644.7±55.0 °C at 760 mmHg |
Molecular Formula | C22H20Cl2N4O4 |
Molecular Weight | 475.325 |
Flash Point | 343.7±31.5 °C |
Exact Mass | 474.086151 |
LogP | 2.39 |
Vapour Pressure | 0.0±1.9 mmHg at 25°C |
Index of Refraction | 1.636 |